Research And Investment Prospect of Human Vaccine Mareket Share, Size, Growth In China, 2014-2018: Radiant Insights, Inc

Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018, mainly studies the market, competition pattern and segmentations of human vaccine industry in China and analyzes the industry chain, import & export and key enterprises of human vaccine in China.

This report analyzes the business performances of 7 key enterprises, including Beijing Tiantan Biological Products Co., Ltd, ChongQing ZhiFei Biological Products Co., Ltd, Walvax Biotechnology Co., Ltd, Liaoning Chengda Co., Ltd (LCD) etc.

As one of powerful vaccine manufacturing countries in world, China has 42 vaccine manufacturers with approval license. In 2013, the total of lot release quantity of vaccines was about 755 million doses, increasing by 0.53% over the 751 million doses in 2012.

Browse Full Report With TOC @ http://www.radiantinsights.com/research/research-and-investment-prospect-of-human-vaccine-industry-in-china

Vaccine manufacturers mainly consist of state-owned enterprises, private enterprises and foreign-funded enterprises in China. Seeing from the lot release quantity of vaccine in 2013, the state-owned enterprises still take the leading position in vaccine market, with market shares of 62%, followed by private enterprises and foreign-funded enterprises successively, with market shares of 33.77% and 4.23% respectively.

Most of market of typeⅠvaccines is still dominated by state-owned enterprises, including 6 largest institutes of China National Biotec-Group Company Limited and Changchun Keygen Biological Products Co., Ltd. Private enterprises take half of market shares of typeⅡvaccines, the representative enterprises include: ChongQing ZhiFei Biological Products Co., Ltd, and Walvax Biotechnology Co., Ltd etc.

While the international enterprises have definite advantages in respects of high-end vaccines and multivalent vaccines, taking pneumococcal vaccines for instance, only one conjugate vaccine is available, say: Pneumococcal 7-Valent Conjugate Vaccine produced by Pfizer. Although, at present, several enterprises are conducting studies on pneumococcal conjugate vaccines, it is still long to launch on the market, with huge uncertainties.

In 2014-2018, the average growth rate of vaccine in China will maintain at 16%-18%. The main driving factors include: implement of national vaccine immunization plan, increasing receptivity of vaccine by people, rising trend of initiative vaccination and increase of type Ⅱvaccines application etc. It can be expected that the market scale of vaccine will hit CNY 40.5 billion in 2018.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Research And Forecast Of Banknote Sorter Market In China, 2014: Radiant Insights, Inc

With the official issuance of the People’s Bank of China’s Guidance on Special Rectification to Mistaken Payment of False Currency by Finance Institutes in Bank Industry (YBF (2013)No.14) in 2013, the currency sorter market in China is facing huge market demand and development opportunity.

According to Huidian Research, because of the drive of strong demand of bank, stimulation of central bank’s policies, mature banknote sorter technology and reasonable price, the market scale of banknote sorter in China is growing rapidly with great growth potential in China.

For more information kindly visit: http://www.radiantinsights.com/research/research-and-forecast-of-banknote-sorter-industry-in-china

Since 2007, the annual average growth rate of market scale of banknote sorter has exceeded 60%, it can be expected that the market scale of banknote sorter can hit CNY 12 billion in 2014.

At present, the small-size banknote sorter industry is still in prosperity upward stage, it is predicted that the rapid growth can be maintained until 2017, the output of this industry will increase fast in overall. The fast increase of output of banknote sorter will concurrent with the price decrease of banknote sorter, it is predicted that the price will decrease by about 5%-10%.

In 2013, Liaoning Julong Financial Equipment Corp’s sale revenue increased by 102.06% over the same period of last year, the market share was almost no changes with 2012.

Shanghai Guao Electronic Technology Co., Ltd’s sales revenue in 2013 was 2.8 times than 2012; GRGBanking entered into banknote sorter market rapidly in 2013, the sales revenue of banknote sorter realized CNY 73.34 million in the same year, in 2014, it continued to maintain fast growth and became another strong competitor in banknote sorter market. Shandong New Beiyang Information Technology Co., Ltd merged Anshan Bozong and entered into this market.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Research And Investment Prospect of Calcium Carbonate Market Share, Size, Analysis In China, 2014-2018: Radiant Insights, Inc

As of 2013, China’s output of calcium carbonate had reached 23 million t and had became the largest calcium carbonate manufacturer in global. In 2013, the outputs of light calcium carbonate and heavy calcium carbonate were 10.5 million t and 12.5 million t respectively.

In recent five years, the annual average growth rate of calcium carbonate industry was about 13%, which met the demand for calcium carbonate by national economy development.

Access This Full Report @ http://www.radiantinsights.com/research/research-and-investment-prospect-of-calcium-carbonate-industry-in-china

At present, there are about 400 light calcium carbonate manufacturers, taking the small and medium-sized enterprises as primary, the manufacturers with annual output exceeding 300,000 t are less than 5%, the number of manufacturers with output exceeding 100,000 t are less than 60, the outputs of the rest of over 300 manufacturers are only 10,000-15,000 t separately.

Seeing from the supply structure of light calcium carbonate, the output of micro-powder calcium and particle calcium accounts for about 70% of total output, active calcium accounts for 12%, and superfine calcium and Nanometer Calcium accounts for 18%.

In 2013, the consumption of calcium carbonate stood at 22.9 million t in China, in which, the consumption in machine-made paper and paper board industry accounted for 36% of total consumption of calcium carbonate, plastic product industry accounted for 31%, coating industry accounted for 14%, and rubber product industry accounted for 5%. In recent years, these industries keep fast growth, which also drives the development of calcium carbonate industry.

As for the calcium carbonate products in China, in respect of total output, the supply meets demand basically, while in respect of product structure, the supply of low and middle grade products exceeds demands, the high grade products are in short supply and needs import.

In China, the fine grinding calcium carbonates (FGCC) used for paper-making and superfine active light calcium (nanometer calcium carbonate) mainly rely on import.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Peru Female Fragrances Market Research, Forecast Profile To 2018: Radiant Insights, Inc

Synopsis

This report presents data on the Female Fragrances consumption trends in Peru. It analyzes Female Fragrances consumption volumes and values at market and category level.

It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.

Access This Full Report @ http://www.radiantinsights.com/research/female-fragrances-market-in-peru-market-profile-to-2018

Summary

Canadean’s “Female Fragrances Market in Peru: Market Profile to 2018” provides data on Peru Female Fragrances market, providing marketers with the essential tools to understand their own and their competitors’ position in the market. Thus allowing them to use the information to accurately identify the areas where they want to compete in the future.

This report brings together Canadean Intelligence’s research, modeling and analysis expertise in order to develop uniquely detailed market data. This allows domestic and foreign companies to identify the market dynamics that account for overall Female Fragrances sales and which categories and segments will see growth in the coming years.

Scope

“Female Fragrances Market in Peru: Market Profile to 2018” provides you with the following:

– Overall Fragrances market analysi

– Female Fragrances market value by category

– Overall Fragrances market analysis by volume

– Female Fragrances market volume by category.

Why should you buy this report?

– Gain insight into the Female Fragrances consumption in Peru.

– Detailed product sales segmentation (for both volumes and values) are provided.

– Forecasts from 2014 to 2018 will allow marketers to understand the future pattern of market trends; from winners and losers to category dynamics and thereby easily indentify the key areas in which they want to compete in the future.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Norway Female Fragrances Market Analysis, Research Profile To 2018: Radiant Insights, Inc

Synopsis

This report presents data on the Female Fragrances consumption trends in Norway. It analyzes Female Fragrances consumption volumes and values at market and category level.

It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.

View Full Report with TOC @ http://www.radiantinsights.com/research/female-fragrances-market-in-norway-market-profile-to-2018

Summary

Canadean’s “Female Fragrances Market in Norway: Market Profile to 2018” provides data on Norway Female Fragrances market, providing marketers with the essential tools to understand their own and their competitors’ position in the market. Thus allowing them to use the information to accurately identify the areas where they want to compete in the future.

This report brings together Canadean Intelligence’s research, modeling and analysis expertise in order to develop uniquely detailed market data. This allows domestic and foreign companies to identify the market dynamics that account for overall Female Fragrances sales and which categories and segments will see growth in the coming years.

Scope

“Female Fragrances Market in Norway: Market Profile to 2018” provides you with the following:

– Overall Fragrances market analysis

– Female Fragrances market value by category

– Overall Fragrances market analysis by volume

– Female Fragrances market volume by category.

Why should you buy this report?

– Gain insight into the Female Fragrances consumption in Norway.

– Detailed product sales segmentation (for both volumes and values) are provided

– Forecasts from 2014 to 2018 will allow marketers to understand the future pattern of market trends; from winners and losers to category dynamics and thereby easily indentify the key areas in which they want to compete in the future.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

New Zealand Female Fragrances Market Size, Growth, Research Profile To 2018: Radiant Insights, Inc

Synopsis

This report presents data on the Female Fragrances consumption trends in New Zealand. It analyzes Female Fragrances consumption volumes and values at market and category level.

It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.

Read Complete Report with TOC @ http://www.radiantinsights.com/research/female-fragrances-market-in-new-zealand-market-profile-to-2018

Summary

Canadean’s “Female Fragrances Market in New Zealand: Market Profile to 2018” provides data on New Zealand Female Fragrances market, providing marketers with the essential tools to understand their own and their competitors’ position in the market. Thus allowing them to use the information to accurately identify the areas where they want to compete in the future.

This report brings together Canadean Intelligence’s research, modeling and analysis expertise in order to develop uniquely detailed market data. This allows domestic and foreign companies to identify the market dynamics that account for overall Female Fragrances sales and which categories and segments will see growth in the coming years.

Scope

“Female Fragrances Market in New Zealand: Market Profile to 2018” provides you with the following:

– Overall Fragrances market analysis

– Female Fragrances market value by category

– Overall Fragrances market analysis by volume

– Female Fragrances market volume by category.

Why should you buy this report?

– Gain insight into the Female Fragrances consumption in New Zealand.

– Detailed product sales segmentation (for both volumes and values) are provided.

– Forecasts from 2014 to 2018 will allow marketers to understand the future pattern of market trends; from winners and losers to category dynamics and thereby easily indentify the key areas in which they want to compete in the future.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Netherlands Female Fragrances Market Share, Trends, Research Profile To 2018: Radiant Insights, Inc

Synopsis

This report presents data on the Female Fragrances consumption trends in the Netherlands. It analyzes Female Fragrances consumption volumes and values at market and category level.

It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.

Browse Full Report With TOC @ http://www.radiantinsights.com/research/female-fragrances-market-in-the-netherlands-market-profile-to-2018

Summary

Canadean’s “Female Fragrances Market in the Netherlands: Market Profile to 2018” provides data on the Netherlands Female Fragrances market, providing marketers with the essential tools to understand their own and their competitors’ position in the market. Thus allowing them to use the information to accurately identify the areas where they want to compete in the future.

This report brings together Canadean Intelligence’s research, modeling and analysis expertise in order to develop uniquely detailed market data. This allows domestic and foreign companies to identify the market dynamics that account for overall Female Fragrances sales and which categories and segments will see growth in the coming years.

Scope

“Female Fragrances Market in the Netherlands: Market Profile to 2018” provides you with the following:

– Overall Fragrances market analysis

– Female Fragrances market value by category

– Overall Fragrances market analysis by volume

– Female Fragrances market volume by category.

Why should you buy this report?

– Gain insight into the Female Fragrances consumption in Netherlands.

– Detailed product sales segmentation (for both volumes and values) are provided.

– Forecasts from 2014 to 2018 will allow marketers to understand the future pattern of market trends; from winners and losers to category dynamics and thereby easily indentify the key areas in which they want to compete in the future.

 

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Mexico Female Fragrances Market Research, Forecast Profile To 2018: Radiant Insights, Inc

Synopsis

This report presents data on the Female Fragrances consumption trends in Mexico. It analyzes Female Fragrances consumption volumes and values at market and category level.

It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.

For more information kindly visit: http://www.radiantinsights.com/research/female-fragrances-market-in-mexico-market-profile-to-2018

Summary

Canadean’s “Female Fragrances Market in Mexico: Market Profile to 2018” provides data on Mexico Female Fragrances market, providing marketers with the essential tools to understand their own and their competitors’ position in the market. Thus allowing them to use the information to accurately identify the areas where they want to compete in the future.

This report brings together Canadean Intelligence’s research, modeling and analysis expertise in order to develop uniquely detailed market data. This allows domestic and foreign companies to identify the market dynamics that account for overall Female Fragrances sales and which categories and segments will see growth in the coming years.

Scope

“Female Fragrances Market in Mexico: Market Profile to 2018” provides you with the following:

– Overall Fragrances market analysis

– Female Fragrances market value by category

– Overall Fragrances market analysis by volume

– Female Fragrances market volume by category.

Why should you buy this report?

– Gain insight into the Female Fragrances consumption in Mexico.

– Detailed product sales segmentation (for both volumes and values) are provided.

– Forecasts from 2014 to 2018 will allow marketers to understand the future pattern of market trends; from winners and losers to category dynamics and thereby easily indentify the key areas in which they want to compete in the future.

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Frontier Pharma: Prostate Cancer – Identifying and Commercializing First-in-Class Innovation By Radiant Insights, Inc

Summary

Exceptionally Large and Innovative Pipeline

The prostate cancer pipeline is among the largest in the pharmaceutical industry with 484 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in this pipeline is exceptional; GBI Research analysis identified 174 first-in-class programs in the prostate cancer pipeline, acting on 122 first-in-class molecular targets.

This accounts for some 36% of all products with a disclosed molecular target and is reflective of the high degree of innovation in this indication. This has far-reaching strategic implications for all market participants, as, despite the high attrition rate in prostate cancer, it is highly likely many of the first-in-class technologies will reach the market over the coming decade and may transform the clinical and commercial landscape.

Alignment of First-in-Class Molecular Target with Disease Causation

One of the key trends in oncology and in prostate cancer in particular over the last decade is the clinical and commercial impact of targeted therapies designed to target proteins in signaling pathways that are strongly associated with disease progression. By aligning the molecular targets for therapeutic intervention with disease causation and/or propagation, these therapies limit the systemic cytotoxic effects whilst inhibiting tumor-promoting signaling pathways. Such strategies thereby typically achieve superior efficacy and safety profiles.

Our proprietary analyses demonstrate significant levels of differentiation as to how well the first-in-class products and their respective molecular targets align to underlying gene and protein level mutations and dysfunction. More advanced analytics further substantiated these findings as strong levels of differentiation in the scientific and clinical rationale for first-in-class molecular targets emerged. Furthermore, clear frontrunners were identified by integrating analyses to assess the accessibility of molecular targets for therapeutic compounds, the size of the target patient population that would benefit from therapeutic intervention, and the expected positioning of the first-in-class products based on the molecular targets and mechanisms of action of currently marketed products.

These insights and a detailed review of the available evidence from scientific studies substantiate the perspective that first-in-class-product technology in its own right is not sufficient to offer a compelling scientific and clinical rationale. However, a range of products offer very significant scientific and clinical promise and could therefore result in a strong commercial proposition with the prospect of clinically and commercially transformative products in the future.

For more information kindly visit: http://www.radiantinsights.com/research/frontier-pharma-prostate-cancer-identifying-and-commercializing-first-in-class-innovation

A Deals Landscape with Numerous Investment Opportunities

Analysis has confirmed that 169 of the 174 first-in-class products have not been involved in a licensing or co-development deal. Although many act on targets that are not yet strongly substantiated in terms of their therapeutic potential in prostate cancer in clinical studies, there are many which are supported by promising in vivo and in vitro preclinical evidence, and as such are highly promising prostate cancer therapies. Indeed, breakthrough innovations are highly desirable as an investment option.

However, most deals involving first-in-class products were either preclinical or Phase I development, whereas advance-in-class and addition-to-class product deals were typically made in Phases II and III, therefore showing significant differentiation. These findings have significant strategic implications for both biotech companies seeking to out-license products and firms with an interest in in-licensing first-in-class products with strong clinical and commercial prospects.

Scope

The report analyzes innovation in prostate cancer, in the context of the overall pipeline and current market landscape. In addition, it analyzed the deals landscape surrounding first-in-class products in prostate cancer, and pinpoints opportunities for in-licensing. The report covers and includes –

– A brief introduction to prostate cancer, including symptoms, pathophysiology, and overview of pharmacotherapy and treatment algorithms.

– The changing molecular target landscape between market and pipeline and particular focal points of innovation in the pipeline.

– Comprehensive review of the pipeline for first-in-class therapies, analyzed on the basis of stage of development, molecule type and molecular target.

– Identification and assessment of first-in-class molecular targets with a particular focus on early-stage programs of which clinical utility has yet to be evaluated, as well as literature reviews on novel molecular targets.

– Assessment of the licensing and co-development deal landscape for prostate cancer therapies and benchmarking of deals involving first-in-class versus non-first-in-class-products.

Reasons to buy

The report will assist business development and enable marketing executives to strategize their product launches, by allowing them to –

– Understanding of the focal shifts in molecular targets in the prostate cancer pipeline.

– Understanding of the distribution of pipeline programs by phase of development, molecule type and molecular target.

– Access a scientific and clinical analysis of first-in-class developmental programs for prostate cancer, benchmarked against non-first-in-class targets.

– Access a list of the first-in-class therapies potentially open to deal-making opportunities

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/

Frontier Pharma: Parkinson’s Disease – Identifying And Commercializing First-In-Class Innovation By Radiant Insights, Inc

Summary

Large Degree of Innovation in Parkinson’s Disease Pipeline

The Parkinson’s disease (PD) pipeline currently has 302 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse range of neuroprotective therapies targeting dysfunctional disease processes. This diversity is partially due to the presence of 90 first-in-class products, which accounts for 37% of the overall pipeline therapies that disclosed their target.

Browse Full Report With TOC @ http://www.radiantinsights.com/research/frontier-pharma-parkinson-s-disease-identifying-and-commercializing-first-in-class-innovation

In an industry, market and development landscape that favors first-in-class over non-first-in-class development in many ways, such as through faster approval or greater revenue, this finding has strategic implications for a wide array of market participants, both large and small. Despite their historically high attrition rate, first-in-class therapies that reach the market have the potential to transform and improve the PD treatment landscape.

Alignment of First-in-Class Molecular Target with Disease Processes and Genetics

PD is a complex and multifaceted disease with a complex interplay between different pathological processes. Enormous research efforts and significant technological advances have furthered knowledge of the neuroanatomy of the basal ganglia and of the fundamental processes underlying neurodegeneration, helped by the ongoing identification of susceptibility genes and causative genes in familial PD.

Although the exact mechanisms that initiate onset remain unclear, these insights have been translated into the pool of novel therapeutic targets, which may potentially become disease-modifying therapies by aligning to the disease processes and some genetic determinants of PD.

GBI Research’s proprietary analysis showed substantial variation in how well the functional roles of PD first-in-class targets align to the pathophysiology of PD. Further in-depth analysis identified the most promising first-in-class targets based on various scientific and clinical parameters. Examining scientific and clinical data of promising first-in-class targets showed that first-in-class status is not, in its own right, enough for a successful product; however, the first-in-class products substantiated by scientific and clinical evidence will be exciting future prospects with the potential to transform the PD market.

First-in-Class Products in Licensing and Co-development Deals

Strategic consolidation is relatively uncommon in the PD market. Concerning first-in-class specifically, only nine first-in-class products that are currently in development have been involved in licensing or co-development deals since 2006. Despite the low sample size, it is clear that the first-in-class PD products offer an attractive investment prospect as they command much higher deal values and, on average, deals occur earlier in development compared to non-first-in-class counterparts.

Browse Full Report With TOC @ http://www.radiantinsights.com/research/frontier-pharma-parkinson-s-disease-identifying-and-commercializing-first-in-class-innovation

Both trends were substantiated by industry-wide data that showed that, particularly in Phase I, first-in-class products would attract larger mean and median total deal values. The data highlight that the first-in-class deals landscape is different and indicates a greater chance of becoming much more lucrative than the deals landscape for addition-to-class or advance-in-class therapies.

A total of 81 first-in-class products that are currently in development have not yet been entered into a licensing or co-development deal. Under a growing unmet need for disease-modifying therapies and increasing understanding of disease processes allowed by technological advances, there are numerous opportunities for strategic alliances to bolster a first-in-class portfolio or fund clinical development. Some of these first-in-class products are supported by promising scientific and clinical data, making them attractive prospects as both therapeutics and investment opportunities.

Scope

The report analyzes innovation in PD in the context of the overall pipeline and current market landscape. It also analyzes the deals landscape surrounding first-in-class products and pinpoints in-licensing opportunities.The report includes –

– A brief introduction to PD, including symptoms, pathophysiology, and an overview of pharmacotherapy and treatment algorithms

– Coverage of the changing molecular target landscape and particular points of innovation in the pipeline

– A comprehensive review of the pipeline for first-in-class therapies, analyzed by stage of development, molecule type and molecular target

– Identification and assessment of first-in-class molecular targets with a particular focus on early-stage programs of which clinical utility has yet to be evaluated, as well as literature reviews of novel molecular targets

– Industry-wide analysis of first-in-class deals compared to non-first-in-class deals

– An assessment of the licensing and co-development deal landscape for PD therapies and benchmarking of deals comparing first-in-class and non-first-in-class-products

Browse Full Report With TOC @ http://www.radiantinsights.com/research/frontier-pharma-parkinson-s-disease-identifying-and-commercializing-first-in-class-innovation

Reasons to buy

The report will enable business development and enable marketing executives to strategize their product launches by allowing them to –

– Understand the focal shifts in molecular targets in the PD pipeline

– Understand the distribution of pipeline programs by phase of development, molecule type and molecular target

– Access a scientific and clinical analysis of first-in-class developmental programs for PD, benchmarked against non-first-in-class targets

– Assess the valuations of licensed and co-developed PD treatments

– Access a list of the first-in-class therapies potentially open to deal-making opportunities

 

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information visit: Radiant Insights

Contact:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Blog URL: http://radiantinsights.weebly.com/